Tadalafil and acetazolamide versus acetazolamide for the prevention of severe high-altitude illness

Eyal Leshem, Yehezkel Caine, Elliot Rosenberg, Yoram Maaravi, Hagai Hermesh, Eli Schwartz

Research output: Contribution to journalArticlepeer-review

Abstract

We report an open-label study comparing tadalafil and acetazolamide (n = 24) versus acetazolamide (n = 27) for prevention of high-altitude illness (HAI) at Mt. Kilimanjaro. Tadalafil group had lower rates of severe HAI compared with controls (4% vs 26%, p = 0.03), mostly because of decreased high-altitude pulmonary edema rates (4% vs 22%, p = 0.06).

Original languageEnglish
Pages (from-to)308-310
Number of pages3
JournalJournal of Travel Medicine
Volume19
Issue number5
DOIs
StatePublished - Sep 2012
Externally publishedYes

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health
  • Infectious Diseases

Fingerprint

Dive into the research topics of 'Tadalafil and acetazolamide versus acetazolamide for the prevention of severe high-altitude illness'. Together they form a unique fingerprint.

Cite this